Healthcare provider profile · identity verified

Nicholas Michael Mascoli, M.D.

Internal Medicine · NEWTON LOWER FALLS, MA · NPI 1013964717

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	899	264
Lisinopril	Lisinopril	635	185
Levothyroxine Sodium	Levothyroxine Sodium	319	77
Amlodipine Besylate	Amlodipine Besylate	309	92
Tamsulosin Hcl	Tamsulosin Hcl	248	72
Losartan Potassium	Losartan Potassium	246	73
Metoprolol Succinate	Metoprolol Succinate	244	76
Hydrochlorothiazide	Hydrochlorothiazide	243	75
Simvastatin	Simvastatin	217	63
Lorazepam	Lorazepam	214	50
Omeprazole	Omeprazole	209	67
Metformin Hcl	Metformin Hcl	206	63
Rosuvastatin Calcium	Rosuvastatin Calcium	184	58
Eliquis	Apixaban	178	52
Atenolol	Atenolol	175	48
Allopurinol	Allopurinol	159	43
Gabapentin	Gabapentin	153	56
Sertraline Hcl	Sertraline Hcl	128	38
Zolpidem Tartrate	Zolpidem Tartrate	110	28
Citalopram Hbr	Citalopram Hydrobromide	100	29
Finasteride	Finasteride	99	28
Oxycodone Hcl	Oxycodone Hcl	90	19
Alprazolam	Alprazolam	86	17
Clonazepam	Clonazepam	86	19
Prednisone	Prednisone	84	38
Trazodone Hcl	Trazodone Hcl	79	30
Pravastatin Sodium	Pravastatin Sodium	74	22
Pantoprazole Sodium	Pantoprazole Sodium	73	24
Albuterol Sulfate Hfa	Albuterol Sulfate	70	35
Jardiance	Empagliflozin	64	19
Fluoxetine Hcl	Fluoxetine Hcl	59	15
Ezetimibe	Ezetimibe	58	21
Valsartan	Valsartan	55	14
Doxycycline Monohydrate	Doxycycline Monohydrate	53	44
Escitalopram Oxalate	Escitalopram Oxalate	53	16
Metformin Hcl Er	Metformin Hcl	53	16
Amitriptyline Hcl	Amitriptyline Hcl	51	14
Furosemide	Furosemide	50	20
Warfarin Sodium	Warfarin Sodium	50	16
Sumatriptan Succinate	Sumatriptan Succinate	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	14
Spironolactone	Spironolactone	47	15
Bupropion Hcl Sr	Bupropion Hcl	46	13
Tramadol Hcl	Tramadol Hcl	45	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	17
Ozempic	Semaglutide	40	11
Diclofenac Sodium	Diclofenac Sodium	39	14
Synthroid	Levothyroxine Sodium	39	11
Nifedipine Er	Nifedipine	36	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Chlorthalidone	Chlorthalidone	34	12
Alendronate Sodium	Alendronate Sodium	32	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Azithromycin	Azithromycin	31	29
Bupropion Xl	Bupropion Hcl	31	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	12
Valacyclovir	Valacyclovir Hcl	30	12
Carvedilol	Carvedilol	29	suppressed
Torsemide	Torsemide	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Oxycontin	Oxycodone Hcl	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Trulicity	Dulaglutide	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Diazepam	Diazepam	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Famotidine	Famotidine	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Glipizide	Glipizide	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Wegovy	Semaglutide	19	suppressed
Estradiol	Estradiol	18	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Erythromycin	Erythromycin Base	15	12
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Tadalafil	Tadalafil	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Butalbital-Acetaminophen	Butalbital/Acetaminophen	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error